Pancreatic Adenocarcinoma Metastatic Recruiting Phase 2 Trials for Pembrolizumab (DB09037)

Also known as: Metastatic Pancreatic Adenocarcinoma / Pancreatic carcinoma metastatic

IndicationStatusPhase
DBCOND0060224 (Pancreatic Adenocarcinoma Metastatic)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03006302Epacadostat, Pembrolizumab, and CRS-207, With or Without CY/GVAX Pancreas in Patients With Metastatic Pancreas CancerTreatment